Director Catherine Sohn to retire, not standing for re-election at 2024 AGM

Jazz Pharmaceuticals plc

Catherine Sohn, Pharm.D. notified board of retirement effective at 2024 annual general meeting.
Decision not due to any dispute or disagreement with company or board on operations, policies, or practices.
No replacement or nominee announced for the departing director position.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Catherine Sohn

Director

JAZZ · Jazz Pharmaceuticals plc

Filed: May 31, 2024, 7:59 PM ET

On May 31, 2024, Catherine Sohn, Pharm.D. notified the board of directors (the “Board”) of Jazz Pharmaceuticals plc (the “Company”), that she is retiring and will not stand for re-election to the Board, when her term expires, at the Company’s 2024 annual general meeting of shareholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Catherine Sohn departed as Director at Jazz Pharmaceuticals plc.

Action: retiring
Role: Director

Exact text from the filing

On May 31, 2024, Catherine Sohn, Pharm.D. notified the board of directors (the “Board”) of Jazz Pharmaceuticals plc (the “Company”), that she is retiring and will not stand for re-election to the Board, when her term expires, at the Company’s 2024 annual general meeting of shareholders.

View on SEC.gov

Jazz Pharmaceuticals plc filing history →

Source: SEC EDGAR

accession 0001193125-24-151941

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.